OTC deficiency is a dubious disease that belongs to the field of genetic metabolism, clinical performance is complex and often involves multiple systems. Early identification and normalisation of clinical trials are essential for improving prognosis. Diagnosis of OTC disease requires a combination of clinical performance, imaging, laboratory testing and pathological checks.
Platforms can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of OTC deficiencies require the development of multiple treatment programs, usually including drug therapy, rehabilitation interventions, and regular follow-up management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many genetic metabolic disorders that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the lack of OTC. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.